Literature DB >> 33426696

Beware of Optimism Bias in the Context of the COVID-19 Pandemic.

Alvaro Pascual-Leone1,2,3, Gabriele Cattaneo3,4, Dídac Macià5, Javier Solana3,4, José M Tormos3,4, David Bartrés-Faz3,5.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33426696      PMCID: PMC8014543          DOI: 10.1002/ana.26001

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


× No keyword cloud information.
The coronavirus (severe acute respiratory syndrome‐coronavirus 2 [SARS‐CoV‐2], coronavirus disease 2019 [COVID‐19]) pandemic has caused over 88 million confirmed cases and nearly 2 million deaths worldwide as of December 2020. Months ago, governments launched unprecedented responses in an attempt to contain the staggering health and economic threats. In most countries, emergency state declarations with strict confinement and quarantine regulations were followed by phased reopening, emphasizing adherence to public health recommendations regarding hand washing, use of masks, and social distance. However, the situation has continued to evolve, and we are witnessing an increase in the number of cases in many regions of the world. We believe addressing this increase in COVID‐19 cases and preventing further waves of the present pandemic particularly as the first vaccines begin to be offered, requires understanding and addressing optimism bias. Optimism bias , refers to the mistaken belief that our chances of experiencing negative events are lower than predicted or than those faced by our peers. Such optimism can be beneficial by reducing stress, controlling anxiety, and promoting physical health. However, dealing with the pandemic requires behavioral changes, adherence to precautions, and adoption of personal hygiene practices that may be uncomfortable and cumbersome. Similarly, early acceptance of vaccine harbors some uncertainties. Individuals with excessive optimism bias are less likely to follow such recommendations if they perceive their individual risk to be low, , which not only puts them, but all of us in danger. Data from the international research and analytics group YouGov (https://yougov.co.uk) reveal that all around the world, people are more worried about the potential health impact of COVID‐19 on others than on themselves. There are, however, striking differences across countries (Fig 1). On average, in the United States, people are about 15% more worried about the health impact of COVID‐19 for others than for their own health, in Europe the average difference is 22%, whereas in the Far East countries it is only 9%. Notably, the disparity in concerns for self versus others across countries is not significantly correlated with the absolute level of fear for self (ρ = −0.15; p = 0.46) or for others (ρ = 0.23; p = 0.27), and is relatively stable across time. This suggests a deeper relation of the disparity in concerns for self versus others with cultural differences. Cultures can be divided into collectivists and individualists. , Individualist cultures, such as those of Europe or the United States, emphasize personal achievement and individual rights even at the expense of group goals. Collectivist culture, such as those of Japan, Korea, or China, emphasize group goals above individual needs or desires. Such cultural differences influence neural activity, for example, in the medial prefrontal cortex, and can thus impact the processing of self‐related information and decision making.
FIGURE 1

Participants were asked, between May and June, in two different questions about their worries for their own health and for that of peers, including family members and friends. The plot displays the percentage of responders who reported greater concerns for the health of others than for their own health. Colors represent different geographical areas. Blue bar represents Europe, yellow bars North America, red bar Australia, purple bars Middle East, and green bars Far East.

Participants were asked, between May and June, in two different questions about their worries for their own health and for that of peers, including family members and friends. The plot displays the percentage of responders who reported greater concerns for the health of others than for their own health. Colors represent different geographical areas. Blue bar represents Europe, yellow bars North America, red bar Australia, purple bars Middle East, and green bars Far East. Further relevant insights can be obtained from the Barcelona Brain Health Initiative (BBHI), a longitudinal cohort study assessing genetic, biological, and lifestyle determinants of brain health. A total of 3,326 individuals (1,955 women; mean age 54.2 ± 7.1 years) completed web‐based questionnaires in up to 4 time‐points, March 20 to 22, April 1 to 3, May 4 to 6, and June 1 to 3, 2020, approximately 1, 3, 7, and 11 weeks following the decree of a national state of emergency and a strictly enforced lock‐down mandate by the Spanish government. As part of our questionnaires, participants were asked about their worries regarding their own health and that of their family and friends. Consistent with the YouGov's results, BBHI participants reported being much more worried about the health impact of COVID‐19 on others than on themselves. Figure 2 summarizes the findings across time relating them to the severity of the pandemic in Spain at the time of the various assessments.
FIGURE 2

Above: Difference in percentage of Barcelona Brain Health Initiative (BBHI) participants who reported being worried or very worried for their own health versus that of others in the 4 different time points tested. Below: Daily deaths in Spain related to coronarivus disease 2019 (COVID‐19) with vertical lines indicating when the data were collected. New COVID‐19 cases increased from about 3,500 to over 7,700 per day from our first survey (March 20–22) to the second (April 1–3), decreasing afterward to 1,000 and 200 new cases per day at the third and fourth time points, respectively. Similarly, daily deaths rose from about 300 to over 900, descending then to 150 and almost 0 along with the 4 time points.

Above: Difference in percentage of Barcelona Brain Health Initiative (BBHI) participants who reported being worried or very worried for their own health versus that of others in the 4 different time points tested. Below: Daily deaths in Spain related to coronarivus disease 2019 (COVID‐19) with vertical lines indicating when the data were collected. New COVID‐19 cases increased from about 3,500 to over 7,700 per day from our first survey (March 20–22) to the second (April 1–3), decreasing afterward to 1,000 and 200 new cases per day at the third and fourth time points, respectively. Similarly, daily deaths rose from about 300 to over 900, descending then to 150 and almost 0 along with the 4 time points. The difference of over 30% in people's concerns about the health of others than their own was present also among BBHI participants with one or more risk factors for COVID‐19 related morbidity and mortality (including age older than 60 years, preexisting obesity, diabetes or cardiovascular disease, and smokers). Similarly, the discrepancy remained when we looked at the subgroup of participants who had themselves been diagnosed with COVID‐19 (n = 153), needed hospitalization for COVID‐related complications (n = 18), had a family member or close friend diagnosed with COVID (n = 1361), hospitalized for it (n = 749), or who died because of it (n = 284). The probability of stronger concerns for self than for others was, however, significantly smaller in women than men (odds ratio = 0.82, p = 0.05) and was negatively correlated with advancing age (odds ratio per 10 years older of 0.56, p < 0.0001). It is tempting to want to interpret the difference in health concerns for self versus others as a sign of empathy. Rather than hypothesizing optimism bias leading to a relative lack of concern for oneself, one could consider a stronger “theory of mind” resulting in greater worries for loved ones and friends. However, the cross‐cultural differences, the gender difference, the age‐relation, and the persistence of the findings in the face of changing objective markers of disease severity, are most consistent with optimism bias. , Optimism bias is a pervasive human trait related to prefrontal activity and cognitive control. , An excessive feeling of personal safety harbors the serious threat of disregarding public health recommendations and failing to adopt personal hygiene practices and precautions that may be uncomfortable and cumbersome but are critical to protect us all. Fortunately, optimism bias can be modulated and collectivist values can be promoted. , Therefore, consideration of psychology and cognitive neuroscience is critical to optimize the educational campaigns to ensure the efficacy of public health policies and the early acceptance of vaccination campaigns in limiting pandemic consequences.

Potential Conflicts of Interest

The authors declared no conflict of interest.
  8 in total

1.  Rethinking individualism and collectivism: evaluation of theoretical assumptions and meta-analyses.

Authors:  Daphna Oyserman; Heather M Coon; Markus Kemmelmeier
Journal:  Psychol Bull       Date:  2002-01       Impact factor: 17.737

2.  The optimism bias.

Authors:  Tali Sharot
Journal:  Curr Biol       Date:  2011-12-05       Impact factor: 10.834

Review 3.  The link between optimism bias and attention bias: A neurocognitive perspective.

Authors:  Laura Kress; Tatjana Aue
Journal:  Neurosci Biobehav Rev       Date:  2017-08-02       Impact factor: 8.989

Review 4.  Deconstructing and reconstructing theory of mind.

Authors:  Sara M Schaafsma; Donald W Pfaff; Robert P Spunt; Ralph Adolphs
Journal:  Trends Cogn Sci       Date:  2014-12-11       Impact factor: 20.229

5.  Neural mechanisms mediating optimism bias.

Authors:  Tali Sharot; Alison M Riccardi; Candace M Raio; Elizabeth A Phelps
Journal:  Nature       Date:  2007-10-24       Impact factor: 49.962

6.  Neural basis of individualistic and collectivistic views of self.

Authors:  Joan Y Chiao; Tokiko Harada; Hidetsugu Komeda; Zhang Li; Yoko Mano; Daisuke Saito; Todd B Parrish; Norihiro Sadato; Tetsuya Iidaka
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

7.  The Barcelona Brain Health Initiative: A Cohort Study to Define and Promote Determinants of Brain Health.

Authors:  Gabriele Cattaneo; David Bartrés-Faz; Timothy P Morris; Javier Solana Sánchez; Dídac Macià; Clara Tarrero; Josep M Tormos; Alvaro Pascual-Leone
Journal:  Front Aging Neurosci       Date:  2018-10-11       Impact factor: 5.750

8.  Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up.

Authors:  Lang Wang; Wenbo He; Xiaomei Yu; Dalong Hu; Mingwei Bao; Huafen Liu; Jiali Zhou; Hong Jiang
Journal:  J Infect       Date:  2020-03-30       Impact factor: 6.072

  8 in total
  5 in total

1.  COVID-19 Pandemic, Risk, and Blame Attributions: A Scoping Review.

Authors:  Manoj Kumar Sharma; Senthil Amudhan; Meghna Achar; Akash Vishwakarma
Journal:  Indian J Psychol Med       Date:  2022-05-08

Review 2.  Human Brain Resilience: A Call to Action.

Authors:  Alvaro Pascual-Leone; David Bartres-Faz
Journal:  Ann Neurol       Date:  2021-07-19       Impact factor: 11.274

3.  TMS-Evoked Prefrontal Perturbation as a Toy Model of Brain Resilience to Stress During the COVID-19 Pandemic.

Authors:  Ruben Perellón-Alfonso; María Redondo-Camós; Kilian Abellaneda-Pérez; Gabriele Cattaneo; Selma Delgado-Gallén; Goretti España-Irla; Javier Solana Sánchez; José María Tormos; Alvaro Pascual-Leone; David Bartrés-Faz
Journal:  Res Sq       Date:  2021-12-13

4.  Motivational factors were more important than perceived risk or optimism for compliance to infection control measures in the early stage of the COVID-19 pandemic.

Authors:  Bjørn Sætrevik; Sebastian B Bjørkheim
Journal:  PLoS One       Date:  2022-09-23       Impact factor: 3.752

5.  Do Primary Care Physicians Contribute to the Immunization Status of Their Adult Patients? A Story of Patients' Overconfidence Coupled With Physicians' Passivity.

Authors:  Thibaut Papis; Christine Clavien
Journal:  Front Med (Lausanne)       Date:  2021-06-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.